These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 10202144)

  • 21. Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation.
    Goldberg Z; Vogt Sionov R; Berger M; Zwang Y; Perets R; Van Etten RA; Oren M; Taya Y; Haupt Y
    EMBO J; 2002 Jul; 21(14):3715-27. PubMed ID: 12110584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK.
    Wang S; Shi X
    Carcinogenesis; 2001 May; 22(5):757-62. PubMed ID: 11323395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Shieh SY; Ikeda M; Taya Y; Prives C
    Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of the p53-mdm2 and p53-MDMX interfaces.
    Böttger V; Böttger A; Garcia-Echeverria C; Ramos YF; van der Eb AJ; Jochemsen AG; Lane DP
    Oncogene; 1999 Jan; 18(1):189-99. PubMed ID: 9926934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
    Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
    Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mdm2 promotes the rapid degradation of p53.
    Haupt Y; Maya R; Kazaz A; Oren M
    Nature; 1997 May; 387(6630):296-9. PubMed ID: 9153395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export.
    Shinozaki T; Nota A; Taya Y; Okamoto K
    Oncogene; 2003 Dec; 22(55):8870-80. PubMed ID: 14654783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the degradation function of Mdm2.
    Kubbutat MH; Ludwig RL; Levine AJ; Vousden KH
    Cell Growth Differ; 1999 Feb; 10(2):87-92. PubMed ID: 10074902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypophosphorylation of Mdm2 augments p53 stability.
    Blattner C; Hay T; Meek DW; Lane DP
    Mol Cell Biol; 2002 Sep; 22(17):6170-82. PubMed ID: 12167711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation.
    Zhang Y; Xiong Y
    Science; 2001 Jun; 292(5523):1910-5. PubMed ID: 11397945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
    Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
    Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sites of in vivo phosphorylation in the MDM2 oncoprotein cluster within two important functional domains.
    Hay TJ; Meek DW
    FEBS Lett; 2000 Jul; 478(1-2):183-6. PubMed ID: 10922493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functions of the MDM2 oncoprotein.
    Freedman DA; Wu L; Levine AJ
    Cell Mol Life Sci; 1999 Jan; 55(1):96-107. PubMed ID: 10065155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Abl neutralizes the inhibitory effect of Mdm2 on p53.
    Sionov RV; Moallem E; Berger M; Kazaz A; Gerlitz O; Ben-Neriah Y; Oren M; Haupt Y
    J Biol Chem; 1999 Mar; 274(13):8371-4. PubMed ID: 10085066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation.
    Koumenis C; Alarcon R; Hammond E; Sutphin P; Hoffman W; Murphy M; Derr J; Taya Y; Lowe SW; Kastan M; Giaccia A
    Mol Cell Biol; 2001 Feb; 21(4):1297-310. PubMed ID: 11158315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
    Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
    J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
    Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
    Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.